About
Remepy develops hybrid drugs that combine pharmaceutical molecules with AI-driven digital protocols to improve clinical outcomes, focusing on conditions like Parkinson’s Disease with therapies such as Hybridopa.
Explore Remepy's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.